These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9131950)

  • 41. Adverse drug reaction reporting by nurses in Sweden.
    Bäckström M; Ekman E; Mjörndal T
    Eur J Clin Pharmacol; 2007 Jun; 63(6):613-8. PubMed ID: 17404719
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Are consumers ready to take part in the Pharmacovigilance System?--a Portuguese preliminary study concerning ADR reporting.
    Matos C; van Hunsel F; Joaquim J
    Eur J Clin Pharmacol; 2015 Jul; 71(7):883-90. PubMed ID: 26004569
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Spontaneous reporting of adverse drug reactions: who reports and what?
    Tubert-Bitter P; Haramburu F; Begaud B; Chaslerie A; Abraham E; Hagry C
    Pharmacoepidemiol Drug Saf; 1998 Sep; 7(5):323-9. PubMed ID: 15073979
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nurses' spontaneous reporting of adverse drug reactions: expert review of routine reports.
    Mendes D; Alves C; Batel Marques F
    J Nurs Manag; 2014 Apr; 22(3):322-30. PubMed ID: 24754750
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adverse drug reactions in the paediatric population in Denmark: a retrospective analysis of reports made to the Danish Medicines Agency from 1998 to 2007.
    Aagaard L; Weber CB; Hansen EH
    Drug Saf; 2010 Apr; 33(4):327-39. PubMed ID: 20297864
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reporting of adverse drug reactions by general practitioners: a questionnaire-based study in the Netherlands.
    Passier A; ten Napel M; van Grootheest K; van Puijenbroek E
    Drug Saf; 2009; 32(10):851-8. PubMed ID: 19722728
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adverse drug reactions at adverse drug reaction monitoring center in Raipur: Analysis of spontaneous reports during 1 year.
    Singh P; Agrawal M; Hishikar R; Joshi U; Maheshwari B; Halwai A
    Indian J Pharmacol; 2017; 49(6):432-437. PubMed ID: 29674797
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adverse drug reaction reporting by general medical practitioners and retail pharmacists in Harare--a pilot study.
    Ball D; Tisócki T
    Cent Afr J Med; 1998 Aug; 44(8):190-5. PubMed ID: 10101417
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Temporal trends in spontaneous reporting of unlabelled adverse drug reactions.
    Haramburu F; Bégaud B; Moride Y
    Br J Clin Pharmacol; 1997 Sep; 44(3):299-301. PubMed ID: 9296328
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interest of a general practitioner pharmacovigilance network to provide drug information: A comparative study in France.
    Jacquot J; Rousseau V; de Canecaude C; Montastruc JL; Durrieu G
    Therapie; 2020; 75(6):617-622. PubMed ID: 32354462
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adverse drug reactions to anthelmintics.
    Bagheri H; Simiand E; Montastruc JL; Magnaval JF
    Ann Pharmacother; 2004 Mar; 38(3):383-8. PubMed ID: 14749518
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The contribution of Ghanaian patients to the reporting of adverse drug reactions: a quantitative and qualitative study.
    Jacobs TG; Hilda Ampadu H; Hoekman J; Dodoo ANO; Mantel-Teeuwisse AK
    BMC Public Health; 2018 Dec; 18(1):1384. PubMed ID: 30563498
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Estimation of the Under-Reporting of Suspected Serious Adverse Drug Reactions in Japan Using An Interrupted Time Series Analysis.
    Ito S; Narukawa M
    Ther Innov Regul Sci; 2022 Mar; 56(2):358-365. PubMed ID: 35124790
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adverse drug reactions reporting in Calabria (Southern Italy) in the four-year period 2011-2014: impact of a regional pharmacovigilance project in light of the new European Legislation.
    Leporini C; Marrazzo G; Mumoli L; Esposito S; Gallelli L; Mangano G; Brancati G; De Francesco EA; Russo E; De Sarro G;
    Expert Opin Drug Saf; 2017 May; 16(5):515-522. PubMed ID: 28395523
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A comprehensive intervention for adverse drug reactions identification and reporting in a Pediatric Emergency Department.
    Morales Ríos O; Jasso Gutiérrez L; Talavera JO; Téllez-Rojo MM; Olivar López V; Garduño Espinosa J; Muñoz Hernández O
    Int J Clin Pharm; 2016 Feb; 38(1):80-7. PubMed ID: 26499501
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Medication safety knowledge, attitudes and practices among community pharmacists in Lebanon.
    Hajj A; Hallit S; Ramia E; Salameh P;
    Curr Med Res Opin; 2018 Jan; 34(1):149-156. PubMed ID: 28758813
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serious adverse drug reactions in older adults notified to pharmacovigilance.
    Charfi R; El Aïdli S; Zaïem A; Kastalli S; Sraïri S; Daghfous R; Lakhal M
    Therapie; 2012; 67(5):465-70. PubMed ID: 23241256
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Exploring sociodemographic and economic factors that promote adverse drug reactions reporting by patients.
    Inácio P; Gomes JJ; Airaksinen M; Cavaco A
    Health Policy; 2018 Mar; 122(3):263-268. PubMed ID: 29128200
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [A retrospective pharmacovigilance analysis: could decreased reporting of suspected adverse reactions generate future safety concerns?].
    Ferrara F; Mancaniello C; Nava L; Salierno A; Casillo R; Trama U; Nava E; Vitiello A
    Recenti Prog Med; 2022 Mar; 113(3):198-201. PubMed ID: 35315450
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Suspected adverse drug reaction reports with oral anticoagulants in Portugal: a pharmacovigilance study.
    Caldeira D; Rodrigues R; Abreu D; Anes AM; Rosa MM; Ferreira JJ
    Expert Opin Drug Saf; 2018 Apr; 17(4):339-345. PubMed ID: 29463153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.